The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Timber Pharmaceuticals, Inc. and its affiliate on November 21, 2023. The affiliate include BioPharmX, Inc. The cases would be jointly administered for administrative and procedural purposes. Timber Pharmaceuticals, Inc. has been designated as the lead debtor.
Trex Wind-down, Inc. OTC Markets
Equities
TMBR
US8870802084
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |